AstraZeneca: positive results in Covid prevention : vimarsan

AstraZeneca announces that results from a Phase III pre-exposure prophylaxis trial against COVID-19 showed that AstraZeneca's sipavibart , an investigational long-acting antibody , demonstrated a...

Related Keywords

Iskra Reic , Astrazeneca , Executive Vice President , Immune Therapies ,